Home
   Our Services:
   Our Team

Media Zone


MediLexicon International and AstraZeneca extend global emarketing agreement

Release date: 05 January 2007

MediLexicon International Limited and AstraZeneca today announced a new 1 year agreement to continue AstraZeneca's global sponsorship of MediLexicon International websites.

The agreement, now in its 5th year, extends AstraZeneca's presence on Medilexicon's 3 flagship health websites; www.MediLexicon.com, www.MedicalNewsToday.com and www.HospitalsWorldwide.com.

Kay Wesley, Global eMarketing Director at AstraZeneca comments; "Our relationship with MediLexicon has continually proved its worth; with continued internal investment and development at MediLexicon in 2007 we again expect to increase the quality and quantity of marketing initiatives targeting both patients and HCPs".

MediLexicon CEO and Editor in Chief, Christian Nordqvist says "we are delighted to extend the agreement with AstraZeneca again, and look forward to another successful year. AstraZeneca are recognised as industry leaders and we aim to play our part in their continued success."

About MediLexicon International:

MediLexicon International Ltd. is a leading Internet publisher of health and medical news and medical information. Our websites and services are free to use and are supported by advertising and educational grants from selected, relevant organisations. The news and information is widely recognised as being timely, accurate and unbiased.

MediLexicon International websites are designed to be intuitive and easy to use, allowing users to find the information they want quickly and efficiently whilst also delivering relevant information from sponsors in a non-intrusive fashion. No registration is required to browse the sites, access our news archives or use the online databases.

Over 2M people visit the websites every month and this figure continues to grow. MediLexicon International has offices in the United Kingdom and Mexico with additional sales and marketing associates in the US and mainland Europe.

For more information please contact us.

###



Back to top of page
2010   © MediLexicon International Ltd